Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Prostatic Neoplasms 1756Urinary Bladder Neoplasms 352Carcinoma, Renal Cell 218Breast Neoplasms 211Neoplasms 165Kidney Neoplasms 159Lung Neoplasms 102Colorectal Neoplasms 95Motor Activity 85Testicular Neoplasms 60Ovarian Neoplasms 54Melanoma 48Colonic Neoplasms 48Pancreatic Neoplasms 44Neoplasm Metastasis 43Non-Muscle Invasive Bladder Neoplasms 42Urinary Incontinence 40Head and Neck Neoplasms 40Carcinoma, Transitional Cell 40Uterine Cervical Neoplasms 39Disease 39Urologic Neoplasms 37Sarcoma 37Recurrence 35Anxiety Disorders 32Stomach Neoplasms 29Endometrial Neoplasms 29Carcinoma, Non-Small-Cell Lung 29Prostatic Hyperplasia 28Lymphoma 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Amyotrophic Lateral Sclerosis × Genitourinary × Clear all
NCT03516994 2024-05-16

EQUALACP

Duke University

Phase NA Completed
790 enrolled
Genitourinary

Amyotrophic Lateral Sclerosis, Heart Failure, Kidney Failure, Chronic, Neoplasm Metastasis, Parkinson Disease, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive, Diabetes Complications, End Stage Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡